Given the analogy with the observations of ct-p150Glued in AD brain samples discussed previously, and its predicted formation in the BD research cohort, this finding may provide some indication of the biochemical mechanisms involved in the beneficial effects of therapeutic interventions which negatively regulate IP3 signaling and PKC. This evidence concerns the gene PRRT2 and Behcet disease.